Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017

Total Page:16

File Type:pdf, Size:1020Kb

Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017 Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017 colorado.gov/cdphe/marijuana-occupational-safety-health Guide to Worker Safety and Health in the Marijuana Industry: 2017 About this guide This guide is intended to help assist employers in the marijuana industry build occupational safety and health programs. While the foundation of this guide includes existing Colorado state and federal regulations, it is not a comprehensive guide to all of the regulations pertaining to occupational safety and health. It should be noted that this guide does not present any new occupational safety and health regulations for the marijuana industry. Marijuana cultivators, extractors, labs and retailers are required to adhere to all regulations established by the Colorado Department of Revenue’s Marijuana Enforcement Division (MED) https://www.colorado.gov/pacific/enforcement/laws-constitution-statutes-and-regulations-marijuana- enforcement. The marijuana industry in Colorado falls under federal OSHA jurisdiction and businesses must comply with OSHA regulations and recordkeeping requirements. In addition to OSHA regulations, marijuana businesses are required to comply with other state regulations including Colorado labor laws, Colorado workers’ compensation laws, Colorado hazardous waste laws, Colorado Pesticide Applicator’s Act, local fire codes, and other regulations that are specific to employment and labor as well as the production of retail and medical marijuana. Guide to Worker Safety and Health in the Marijuana Industry: 2017 About the Colorado Marijuana Occupational Health and Safety Work Group The Colorado Marijuana Occupational Health and Safety Work Group is a multidisciplinary group that was convened to draw on expertise and experiences of many professionals in the Colorado community. The committee included professionals with a variety of skill sets, including epidemiologists, medical doctors, industrial hygienists, safety professionals, and regulatory specialists, which resulted in a thorough review of the potential occupational safety and health issues in the industry. The larger committee had several subcommittees that contributed to the production of this document. As the committee continues to meet, it is the intention that this guide will continue to grow to add information on how the industry can continue to address safety and health issues. We would like to thank the following people and their respective organizations for their participation in the Colorado Marijuana Occupational Health and Safety Work Group: Associates in Occupational and Environmental Health, LLC Cynthia Ellwood, Ph.D., CIH, FAIHA Boulder County Department of Public Health Bill Hayes Mike Richen, CIH Ambra Sutherlin Center for Health, Work & Environment, Colorado School of Public Health, University of Colorado Anschutz Medical Campus Lee Newman, MD, MA Liliana Tenney, MPH C&IH Ventilation Engineering Bill Mele, CIEC Colorado Department of Public Health and Environment Dara Burris, MPH Mike Van Dyke, Ph.D.,CIH Roberta Smith, RN, MSPH, CIH Shannon Barbare Chris Lane Megan Snow, MS, CHES Elyse Contreras, MPH Edward Smith Meredith Towle, MPH City of Aurora Dave Jeary, MS, CSP City of Longmont Michelle Cogswell Guide to Worker Safety and Health in the Marijuana Industry: 2017 Colorado Department of Agriculture Mike Rigirozzi Laura Quakenbush, Ph.D. John Scott Colorado State University Gwenith Fisher, Ph.D Joshua Schaeffer, Ph.D, MS Kevin Walters, MS Colorado State University- OSHA Consultation Program Casey Barnes, MS, CSP Del Sandfort, CIH Layne Sargent, MS, CIH Denver Environmental Health Emily Backus Janet Burgesser Kirk Whitehead Good Chemistry Laura Davis Green Hygiene, LLC Sarah Kaiman, CIH, CHMM Integrated Occupational Health and Safety- Doug Herrick, CIH, CSP Jeff Pothast & Associates INC. Jeff Pothast, CIH Marijuana Industry Group National Jewish Health Lisa Barker, CCRC, MPH Alison Welch, MS NIOSH Western States Office Elizabeth Dalsey Max Kiefer, MS, CIH Bradley King, Ph.D., MPH, CIH The OSHA Connection, LLC Jolene Donahue, CSHS, OT Pinnacol Assurance Allison Hoskins, AINS Guide to Worker Safety and Health in the Marijuana Industry: 2017 TriCounty Health Department Michele Kinshella, MS, CIH University of Colorado- Department of Environmental & Occupational Health John Adgate, Ph.D., MSPH University of Colorado- Occupational Health Residency Brian Williams, MD University of Colorado Denver Marty Otañez, Ph.D., Contributing Authors Elyse Contreras, Laura Davis, Jolene Donahue, Mike Elliott, Cynthia Ellwood, Allison Hoskins, Bradley S. King, Michele R. Kinshella, Chris Lane, Marty Otañez, Layne Sargent, Joshua Schaeffer, John Scott, Roberta Smith, Alison Welch, and Mike Van Dyke. Guide to Worker Safety and Health in the Marijuana Industry: 2017 Executive Summary Executive Summary At the time of this writing, 28 states and the District of Columbia currently have laws legalizing marijuana in some form. While many studies have focused on health outcomes and public safety issues, little attention has been focused on occupational safety and health associated with this industry. Prior to its legalization, occupational safety and health hazards associated with producing illegal marijuana were documented in published literature and law enforcement reports.1 Washington was the first state to develop formal guidance for the industry, such as the Regulatory Guidance for Licensed I-502 Cannabis Operations (https://fortress.wa.gov/ga/apps/sbcc/File.ashx?cid=4655). Our workgroup sought to identify various types of occupational hazards encountered in this industry and build a document to assist the industry and its workforce in building effective safety and health programs for their businesses. Our team included professionals with a variety of skill sets, including epidemiologists, medical doctors, industrial hygienists, safety professionals, and regulatory specialists, which resulted in a thorough review of the potential occupational safety and health issues in the industry. The State of Colorado Marijuana Enforcement Division’s (MED) Retail Marijuana Code, 1 CCR 212-1 and CCR 212-2, have specific regulations written for the marijuana industry in Colorado. This document is informational only and is not intended to replace or supplement regulations from Colorado’s MED Retail Marijuana Code or from the U.S. Occupational Safety and Health Administration (OSHA). The best practices in this document are suggestions and do not establish any new enforceable regulations by the State of Colorado. Furthermore, this guide is not intended to provide a comprehensive list of existing federal, state, and local regulations that may apply to the marijuana industry. Purpose, scope, and users of the guide The complicated nature of the hazards present in the marijuana industry highlights the need for careful attention to safety and health at all types of marijuana businesses. The purpose of this guide is to provide an overview of the safety and health hazards that may be present in the cultivation, processing and sale of marijuana. Not all hazards listed in this guide may be present at a given facility. Conversely, there may be additional hazards not listed within the scope of this guide that may be present at a given facility. This guide is intended to provide a starting point for the assessment and evaluation of occupational health hazards. This guide also provides abbreviated guidance and a list of resources to help employers in the marijuana industry develop an occupational health and program. Guide objectives The objectives of this guide are to: ● Assist in the recognition of occupational health hazards that might be present within the marijuana industry. ● Identify specific existing federal, state, and local safety and health related regulations that may apply to the marijuana industry. ● Provide initial recommendations for engineering, administrative and personal protective equipment controls that can be used to help eliminate or reduce hazards in the marijuana industry. ● Provide information and resources to assist employers in developing written workplace safety and health programs. ● Provide information to help develop marijuana worker safety training programs. 1 Martyny JW, S. K. (2013). Potential Exposures Associated with Indoor Marijuana Growing Operations. Journal of Occupational and Environmental Hygiene , 622-639. Guide to Worker Safety and Health in the Marijuana Industry: 2017 i Executive Summary Guide roadmap Part 1 of the guide begins with the initial steps that can be performed to establish a safety and health program within a facility. Given this initial background in Part 1, Part 2 provides more detail in two separate sections. Section I ● Outlines the hazards for the industry by category (biological, chemical, and physical). ● For each hazard a general description is given followed by: o Information on the job role that might be specifically affected by the hazard o Considerations for a hazard assessment o Best practices for eliminating or managing the hazard o Federal, state, or local regulations that may apply to that hazard o Additional resources to assist in hazard recognition and management. Section II ● Outlines broader safety and health programs that should be implemented within the industry and provides examples and tools to help develop these programs. ● The programs in Section II are broader programs (e.g. hazard communication and hearing conservation) in which, if needed,
Recommended publications
  • Cannabis (Sub)Culture, the Subcultural Repository, and Networked Mediation
    SIMULATED SESSIONS: CANNABIS (SUB)CULTURE, THE SUBCULTURAL REPOSITORY, AND NETWORKED MEDIATION Nathan J. Micinski A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF ARTS May 2014 Committee: Ellen Berry, Advisor Rob Sloane © 2014 Nathan Micinski All Rights Reserved iii ABSTRACT Ellen Berry, Advisor Subcultural theory is traditionally rooted in notions of social deviance or resistance. The criteria for determining who or what qualifies as subcultures, and the most effective ways to study them, are based on these assumptions. This project seeks to address these traditional modes of studying subcultures and discover ways in which their modification may lead to new understandings and ways of studying subcultures in the contemporary moment. This will be done by suggesting a change in the criteria of examining subcultures from that of deviance or resistance to identification with a collection of images, symbols, rituals, and narratives. The importance of this distinction is the ability to utilize the insights that studying subcultures can offer while avoiding the faults inherent in speaking for or at a subculture rather than with or from it. Beyond addressing theoretical concerns, this thesis aims to apply notions of subcultural theory to study the online community of Reddit, in particular, a subset known as r/trees–a virtual repository for those images, symbols, rituals, and narratives of cannabis subculture. R/trees illustrates the life and vibrancy of a unique subcultural entity, which to this point has evaded a cultural studies analysis. To that end, this project advocates for the importance of the cultural studies approach to analyzing cannabis subculture and further, to insert the findings of this study into that gap in the literature.
    [Show full text]
  • CBD-Rich Cultivars Becoming Available to Patients As Lab Starts Testing MJ for Pathogens and Cannabinoids
    O’Shaughnessy’s • Summer 2009 CBD-rich Cultivars Becoming Available to Patients as Lab Starts Testing MJ for Pathogens and Cannabinoids By Fred Gardner dispensary. Harborside proprietor Steve DeAngelo has Another Steep Hill supporter, Michael Backes A plant strain relatively rich in cannabidiol (CBD) backed the project from its inception. “If you’re calling (AKA ‘Morpheus’) of the Cornerstone Research has been identified by an analytic-chemistry lab for regulation, you’ve got to get ready for inspection Collective in Los Angeles, says, “This is a wonder- recently established to serve the medical cannabis by public health authorities,” DeAngelo says. ful experiment that is taking place in California –but industry in California. somebody has to keep an eye on what’s being provided CBD is a cannabinoid with intriguing medical po- to patients.” tential that gets bred out of cannabis when the breeder’s Promoting quality control is a mission shared by the goal is high THC content (as it has been in California “Clean Green” organic certification program, the Medi- for generations). It has long been assumed that current cal Cannabis Safety Council, and other industry groups. strains contained at most 0.1 percent CBD. As longtime activist Michele Nelson puts it, “the whole The availability of cannabis that is approximately industry is in a transition towards professionalism.” five percent CBD by weight will enable doctors and patients to test its effectiveness in treating various “Some people will have to clean up their conditions. acts,” DeAngelo says. “It can’t be the whole family and friends sitting around CBD-rich cannabis might appeal to with all the dogs in the living room.
    [Show full text]
  • (A-9-THC) Content in Herbal Cannabis Over Time
    32 Current Drug Abuse Reviews, 2012, 5, 32-40 Increasing Delta-9-Tetrahydrocannabinol (-9-THC) Content in Herbal Cannabis Over Time: Systematic Review and Meta-Analysis Fidelia Cascini*,1, Carola Aiello2 and GianLuca Di Tanna3 1Istituto di Medicina Legale, Università Cattolica del S. Cuore, largo F. Vito, 1 00168 Roma, Italy 2Department of Informatics and Systemics, University ‘La Sapienza’, 00185 Rome, Italy 3Department of Public Health and Infectious Diseases, University "La Sapienza", 00185, Rome, Italy Abstract: Aim: The objective of this meta-analysis is to assess the data regarding changes in herbal cannabis potency over time (from 1970 to 2009). Methods: Systematic searches of 17 electronic scientific databases identified studies on this topic, within which 21 case series studies satisfied our inclusion criteria of reporting the mean tetrahydrocannabinol (THC) value per number of samples per year. No language, publication date, publication type or status restrictions were imposed. The study selection and data extraction processes were performed independently but uniformly by two authors, included screening, determination of eligibility and inclusion of the eligible studies in the systematic review, and a meta-analysis of the results on THC content in herbal cannabis samples. We considered papers and not monographic scientific publications, rejecting all studies that were not focused on the subject of this review. Results: Meta-analysis by year was performed on 21 studies containing 75 total mean THC observations from 1979 to 2009 using the random effects model. The results revealed much variability between studies. Further, there was a significant correlation between year and mean THC in herbal cannabis. The combined data indicated the correlation between year and mean THC in herbal cannabis, revealing a temporal trend of increasing potency (5% above the mean THC value in the Poisson regression analysis).
    [Show full text]
  • Economic Impact of Cannabis in San Diego County
    Economic Impact of Cannabis in San Diego County 2021 California State University San Marcos Cannabis Points of Contact: (CSUSM) Virginia Casey, Blue Water Government Office of Business Research and Analysis Affairs, Communications Director (OBRA) Dallin Young, Blue Water Government Affairs, 333 S. Twin Oaks Valley Road President San Marcos, CA 92096 www.csusm.edu/coba Research Team Leads: Johnny Martinez Cannabis Organization: Sofia Rodriguez Dallin Young President Research Team Members: Blue Water Government Affairs Amanda Boudreault Samantha Hoover Publishers: Riley McLaughlin Miguel de Jesus, CSUSM Liz Yocom Roger Herzler, CSUSM Judith Opdahl, CSUSM Layout: Amanda Boudreault Administrative Support Sofia Rodriguez Giselle Bazan For questions about this report, contact: Miguel de Jesus [email protected] (760) 750 - 4266 Executive Summary The cannabis industry has gone through many series of events that has brought it to the billion dollar industry it is today. Since its move from the illicit market, to the legalization of medicinal cannabis in 1996, and continued positive shifts of perceptions of cannabis, there has been exponential growth in the industry. The Office of Business Research and Analysis (OBRA) has analyzed the general impact of the cannabis industry in San Diego County. Throughout this research, OBRA sought to find how adult-use and medicinal cannabis sales increases in revenue and influences the community regarding finances, police enforcement, cannabis license types, public health, and social equity. The cannabis industry yields a considerable amount of revenue to municipalities from cannabis city taxes. Data from public records requests from the cities of San Diego, La Mesa, and Vista illustrate the amount of money by quarter that each city has brought in since their legalization of medicinal cannabis and or adult-use cannabis.
    [Show full text]
  • Marijuana: What the Evidence Shows at It Relates to the Impact of Use and What Can Be Learned from Washington State and Colorado.”
    Kevin A. Sabet, Ph.D. Director, University of Florida Drug Policy Institute, Department of Psychiatry, Division of Addiction Medicine Director, Project SAM (Smart Approaches to Marijuana) Author, Reefer Sanity: Seven Great Myths About Marijuana Before the House and Senate Judiciary Committees, State of Oregon January 17, 2013 Written Testimony “Marijuana: What the evidence shows at it relates to the impact of use and what can be learned from Washington State and Colorado.” Chairman and distinguished members of the Committee, thank you for providing me with the opportunity to appear before you today to discuss marijuana policy and appropriate federal responses. I have studied, researched, and written about drug policy, drug markets, drug prevention, drug treatment, criminal justice policy, addiction, and public policy analysis for almost 18 years. Most recently, from 2009-2011, I served in the Obama Administration as a senior drug policy advisor. I am currently the co-founder, with former Congressman Patrick J. Kennedy, of Project SAM (Smart Approaches to Marijuana). I am also the author of Reefer Sanity: Seven Great Myths About Marijuana (Beaufort). In fact, in my new book, I outline the precise reasons why we in the Obama Administration rejected legalization time and time again when presented with it. Our experience, when talking with parents, prevention and treatment providers, medical associations, law enforcement, and others, was that opening up a legal market for any current illicit drug would be disastrous for public health and safety. Indeed, in the Obama Administration’s inaugural and subsequent drug control strategies, marijuana legalization is explicitly rejected. That is why numerous groups and I found the recent guidance by the U.S.
    [Show full text]
  • Cannabis Business License Screening Applications Top Scoring Applicants
    CITY OF WEST HOLLYWOOD CANNABIS BUSINESS LICENSE SCREENING APPLICATIONS TOP SCORING APPLICANTS December 18, 2018 City of West Hollywood California 1984 www.weho.org/cannabis WEST HOLLYWOOD CANNABIS BUSINESS LICENSE APPLICATION PROCESS On November 20, 2017, after significant members with diverse/unique perspectives community outreach, consultation with and a wide breadth of experience in cannabis industry experts, and City Council cannabis, hospitality, design, business, local discussion, the West Hollywood City Council government licensing, social justice, drug adopted a Cannabis Ordinance allowing a policy reform, as well as familiarity with West variety of different cannabis businesses to be Hollywood. In total, the weighting criteria licensed in the City. The ordinance included for each license type consisted of between the following type and number of cannabis 53 and 56 unique categories with a total of business licenses: between 200 and 205 points. ADULT-USE RETAIL: During the month of May 2018, applicants 8 licenses were allowed to submit cannabis screening applications to the City. The City received CONSUMPTION LOUNGE over 300 screening applications from over (Smoking, Vaping, Edibles): 120 different applicants (most applicants 8 licenses submitted applications in multiple categories). The application evaluation CONSUMPTION LOUNGE committee members began their review (Edibles Only): of applications in July and completed 8 licenses their review in late November. In total, each application evaluation committee DELIVERY SERVICES member reviewed over 20,000 pages, and (Located in West Hollywood): individually scored each application based 8 licenses on the weighting criteria. Once all of the application evaluation committee members MEDICAL DISPENSARY: were finished scoring, the five committee 8 licenses member scores for each application were averaged.
    [Show full text]
  • 4Hr Course Outline: Marijuana Update
    4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* Goals and Objectives: The course will cover current techniques and trends associated with the manufacturing, packaging and sales of concentrated cannabis. This course will also outline dangers associated with the manufacturing of butane honey oil, as well as the dangers associated with alcohol based solvents used in the extraction process of concentrated cannabis. I. Registration and Orientation. A. Introduction B. Course Objectives II. Hash oil, or concentrated cannabis? A. What is hash oil or concentrated cannabis? B. How is it made? 1. Chemicals used in the extraction 2. Different manufacturing techniques C. Slang terms/names for hash oils III. Why concentrated cannabis? A. THC percentages B. Transportation concerns C. Monetary values 4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* IV. Chemical properties and purity of solvents. A. Impurities in solvents that affect outcomes of extraction 1. Water 2. Fill Chemicals 3. Additives B. Polarity of solvents 1. Polar solvents 2. Non-polar solvents 3. Semi-polar solvents C. Solvents 1. Water 2. Ethyl/ethanol/grain alcohol 3. Isopropyl alcohol 4. Hexane 5. Propane 6. Butane V. Bubble hash and Kief hash A. Bubble hash 1. How it’s manufactured 2. Forms 3. Dollar amounts B. Kief hash 1. How it’s manufactured 2. Forms 3. Dollar amounts 4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* VI. Applicable California law A. California Health and Safety Code 11379.6 B. California Penal Code 452(a) C. California Penal Code 452(b) VII. Butane honey oil extraction A. Butane facts 1. Boiling point 2. Flashpoint 3. Explosive limits of butane 4.
    [Show full text]
  • HOUSE BILL No. 2184
    Session of 2021 HOUSE BILL No. 2184 By Committee on Federal and State Affairs 2-1 1 AN ACT concerning health and healthcare; enacting the Kansas medical 2 marijuana regulation act; relating to medical cannabis; licensure and 3 regulation of the manufacture, transportation and sale of medical 4 cannabis; providing certain fines and penalties for violations; amending 5 K.S.A. 44-1009, 44-1015, 65-28b08, 79-5201 and 79-5210 and K.S.A. 6 2020 Supp. 21-5703, 21-5705, 21-5706, 21-5707, 21-5709, 21-5710, 7 23-3201, 38-2269, 44-501, 44-706 and 65-1120 and repealing the 8 existing sections. 9 10 Be it enacted by the Legislature of the State of Kansas: 11 New Section 1. The provisions of sections 1 through 46, and 12 amendments thereto, shall be known and may be cited as the Kansas 13 medical marijuana regulation act. 14 New Sec. 2. As used in the Kansas medical marijuana regulation act, 15 section 1 et seq., and amendments thereto: 16 (a) "Academic medical center" means a medical school and its 17 affiliated teaching hospitals and clinics. 18 (b) "Associated employee" means an owner or prospective owner, 19 officer or board member or prospective board member of an entity seeking 20 a retail dispensary license. 21 (c) "Board of healing arts" means the state board of healing arts. 22 (d) "Caregiver" means an individual registered pursuant to section 8, 23 and amendments thereto, who may purchase and possess medical 24 marijuana in accordance with section 11, and amendments thereto.
    [Show full text]
  • What Providers Should Know About Patients Using Cannabis Carol Freedman Rph, BCGP Objectives
    What Providers Should Know About Patients Using Cannabis Carol Freedman RPh, BCGP Objectives 1. Overview & understanding of cannabis products; availability and access 2. Awareness of potential drug interactions with cannabis 3. Evidence of Efficacy / Inefficacy 4. Discussion of “complementary alternative medicines” (CAM); cannabis use; documentation in medical chart 5. Talking points for patients using cannabis Pharmaceutical- vs Dispensary-Sourced Cannabinoids: What's the Difference? Authors: Daniel Friedman, MD, MSc; Anup D. Patel, MD Cannabis Background Cannabis = synonym for marijuana FDA Approved, Recreational (Adult-Use) & Medical Marijuana (MMJ) Federal: – Schedule I in the US – US federal law prohibits all possession, sale, and use of marijuana – Most parts of the cannabis plant and its derivatives (exception: Hemp derived CBD is legal < 0.3% THC) Massachusetts: – Cannabis Control and Advisory Board - ensures safe access to marijuana; may possess 1 oz./10 oz. at home Cannabis Plant Family 3 major species : – cannabis sativa (most common, highest level of THC) – cannabis indica (typically more CBD than THC) – cannabis ruderalis (few psychogenic properties) 3 major types of cannabinoinds; > 100 chemical entities: Plant (phytonacannabinoids) Synthetic Endogenous Phytonacannabinoids - therapeutic activity – THC (delta-9-tetrahydrocannabinol) psychotropic activity – CBD (cannabidiol) non-psychotropic activity – Terpenes – responsible for smell and taste of cannabis How Cannabis Works Endocannabinoid System (ECS) – Internal Homeostatic
    [Show full text]
  • Quarterly Report Potency Monitoring Project Report
    QUARTERLY REPORT POTENCY MONITORING PROJECT REPORT 104 December 16, 2008 thru March 15, 2009 National Institute on Drug Abuse Contract Number: NOJDA-5-7746 02 /lltf~ Mabm't:. EISobJ;,II:D: Director NIDA Marijuana Project National Center for Natural Products Research a Division of the Resean:b Institute of Pharmaceutical Sciences The School of Pharmacy University of Mississippi University, Mississippi 38677 TABLE OF CONTENTS List of Figures ............................................................................................................................... 3 Summary ................................................................................................................................ 4 Introduction ................................................................................................................................ 5 Table 1. Prevalence of High Potency Marijuana (1989-Present) Between December 16, 2008 to March 15, 2009 ................................................ 7 Table 2. Non-normalized Cannabinoid Averages of Illicit Cannabis Samples by Year Seized ...................................................................................................... 8 Table 3. Comparison of Non-normalized 9-THC Concentration in Different Forms by year Confiscated, 1985-2008 .............................................................. 10 Table 4. Non-normalized 9-THC Averages of Illicit Cannabis Samples Analyzed through March 15, 2009(PM vs. ST) ................................................. 11 Table 5. Domestic
    [Show full text]
  • An Antipsychotic?
    The ABCDs of Overcoming Roadblocks to recovery in First episode psychosis Matcheri S Keshavan MD MAPNET, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical School MH 64023; 60902; 92440, Commonwealth Research Center and a FEPTAC grant by DMH. No other relevant disclosures STAGES OF RECOVERY Worse Stage 1: Symptom stabilization Better Stage 2: Functional Stage 3: recovery Acceptance, Integration Worse Weeks Months Years Key points • What are the outcome trajectories in schizophrenia? • How can we predict outcome? – Non-malleable – Malleable • How we can overcome these obstacles? • Summary and next steps The Kraepelinian pessimism of Dementia praecox And Bleulerian optimism The patient may never achieve restitutio ad integrum Bleuler 1911 The sooner patients can be restored to an earlier life and the less They are allowed to withdraw into the world of their own ideas, The sooner do they become socially functional Bleuler 1908 Outcome in schizophrenia is variable Single Episode, full remission 40% Episodic, without Inter-episode deficits Episodic, w/inter-episode 30% deficits Chronic, Persistent/ 30% Ciompi, Bleuler, Jablenski declining Outcome can be improved by appropriate intervention at any phase of illness The “snowballing effect” in the course of schizophrenia Premorbid deficits Negative family and societal response Prodromal Psychotic/ negative sx Ist psychotic episode Sec negative Stresses of adolescence Untreated Sx “Neurotoxicity” Fear, denial, Stigma, Substance abuse Relapse Med side effects,
    [Show full text]
  • Organoleptic Blueprinting Product Design to Please the Senses
    A PUBLICATION Cannabis on Collision Course with Science extractionmagazine.com ISSUE 12 Jan/Feb 2020 The Delicate Preservation of Cannabis’s Nectar of Bringing Out the the Gods Artist in Every The Gooey Extractor Beauty Crafted A Marriage of Skill by Compression and Creativity Talkin' Cannabis Scaling from Bench-top Edibles Utilizing Space Age to Pilot Science for Cannabis The Metamorphosis Product Design from Miniature to Mammoth when Meeting Consumer Demands Organoleptic Blueprinting Product Design to Please the Senses TURNKEY SOLUTIONS FOR SOLVENT RECOVERY, DISTILLATION, AND ISOLATE PRODUCTION INVEST IN THE BEST CascadeINVEST Sciences utilizes IN the THE best quality, BEST pharmaceutical-grade components by world class OEMS – delivering maximum performance, extended reliability & repeatability and faster ROI. Heidolph Industrial Rotary Evaporator • Scalable to 24/7 continuous operation EVAPORATE • Expect 10+ yrs of performance, industry best 3 year warranty • Less Breakage, product loss - flask support system allows for safe single-user flask handling • Installation, training & NRTL certification included Cascade Sciences PUREPATH 100 Distillation Package • Produce > 2L / hr distillate • Short leadtimes • Installation & Training included • Components have 1-2-3 year warranties DISTILLATE • Keep your distillate clean with GREASLESS JOINTS! • NRTL Certified Components Cascade Sciences C10 Isolate Reactor • Process up to 6L isolate per run • Reactor Vessel lid securely swings to the side, allowing for easier isolate removal • Programmable, precise temp controls for each process step • Oil-free vacuum pump eliminates contamination risk ISOLATE SHORT LEAD TIMES - Order online today at cascadesciences.com. Use code EMag5 to save 5%, with free shipping! Heidolph North America Cascade Sciences 224-265-9600 | HeidolphNA.com 503-847-9047 | cascadesciences.com @heiVape @cascade_botanical Contents Bringing Out the Artist 06 in Every Extractor Organoleptic Blueprinting Publisher 10 MACE Media Group CEO Celeste Miranda 16 Talkin’ Cannabis Edibles Editor-in-Chief Jason S.
    [Show full text]